Competitive Technologies Announces Patent For Nanotechnology Bone Biomaterial Issued

Nov 01, 2004, 00:00 ET from Competitive Technologies, Inc.

    FAIRFIELD, Conn., Nov. 1 /PRNewswire-FirstCall/ -- Competitive
 Technologies, Inc. (Amex:   CTT) announced today that patent number 6,808,561
 has been issued by the US Patent Office for Dr. Brian R. Genge's
 nanotechnology bone biomaterial developed at the University of South Carolina
 (USC). CTT has an exclusive agreement with the University of South Carolina
 Research Foundation to license and commercialize the nanotechnology, an
 injectible calcium phosphate-based biomaterial. Dr. Genge is a research
 professor in the Department of Chemistry and Biochemistry at USC.
     "The granting of this patent recognizes the unique qualities of Dr.
 Genge's innovative nanoparticle biomaterial technology," said Suzanne N. B.
 Alent, CTT's VP Marketing and Business Development. "CTT has an agreement with
 a major dental products company to research the manufacture and use of this
 nanotechnology for dental applications. We will continue to aggressively
 market this superior technology for all aspects of its capabilities."
     In addition to its use in the dental field, the patented nanotechnology
 can also be applied to a variety of human orthopedic procedures, especially
 related to the spine and craniofacial reconstruction, as well as veterinary
 uses. The bone biomaterial technology is an easily flowable, moldable paste
 that conforms to and interdigitates with the host bone. It rapidly hardens
 itself in vivo, forming a solid bone-like structure capable of stabilizing
 fractured bone within 15 minutes and supports the growth of cartilage and bone
 cells. The technology has superior compressive strength making it suitable for
 weight and non-weight bearing bones, and is both machinable and drillable.
     John B. Nano, CTT's President and CEO said, "CTT is proud to continue its
 successful relationship with USC and Dr. Genge. We are building and renewing
 our strong, global alliances with universities, companies and individual
 inventors. Bone biomaterial is just one of the exciting technologies in CTT's
 innovative portfolio. We are actively marketing and commercializing several
 technologies, including homocysteine assays, video compression and decoding
 technology, sexual dysfunction treatment, sunless tanning application, silicon
 carbide wafer testing, encryption technology, EZSpeech(TM) language-mastering
 software, an anti-cancer compound and the Therapik(R) device."
     About Competitive Technologies, Inc.
     Competitive Technologies, established in 1968, is a full service
 technology transfer and licensing provider focused on the technology needs of
 its customers and transforming those requirements into commercially viable
 solutions. CTT is a global leader in identifying, developing and
 commercializing innovative technologies in life, digital, nano, and physical
 sciences developed by universities, companies and inventors. The global market
 for technology transfer services is estimated at $150 billion annually. CTT
 maximizes the value of intellectual assets for the benefit of its customers,
 clients and shareholders. Visit CTT's website:
     Statements about our future expectations, including development and
 regulatory plans, and all other statements in this document other than
 historical facts are "forward-looking statements" within the meaning of
 applicable Federal Securities Laws, and are not guarantees of future
 performance. These statements involve risks and uncertainties inherent in our
 business, including those set forth in Item 7 under the caption "Risk
 Factors," in our most recent Annual Report on Form 10-K filed with the SEC on
 October 29, 2004, and other factors that may be described in our other filings
 with the SEC, and are subject to change at any time. Our actual results could
 differ materially from these forward-looking statements. We undertake no
 obligation to update publicly any forward-looking statement.
      Direct inquiries to:  Johnnie D. Johnson, Strategic IR, Inc.
                            Tel. (212) 754-6565; Fax (212) 754-4333

SOURCE Competitive Technologies, Inc.